Texas OB/GYN: My Existence Is In Violation Of The New Abortion Law
By Michel Martin,
NPR
| 08. 29. 2021
Photo by Do512 on Flickr
Ahead of Texas' abortion ban going into effect on Sept. 1, NPR's Michel Martin speaks with Dr. Ghazaleh Moayedi, an OB/GYN, about what it means for abortion providers and patients there.
MICHEL MARTIN, HOST:
Texas has passed one of the nation's most restrictive abortion bans, and it is just days from becoming law. Barring legal challenges, Senate Bill 8 is set to go into effect on Wednesday. The law signed by Governor Greg Abbott this spring bans abortions as early as six weeks after conception and allows Texans to sue anyone who aids, abets or performs an abortion past that mark. There are no exemptions for cases involving rape or incest.
Doctors and other medical providers around the state have been outspoken in their opposition to the bill. In May, more than 200 Texas physicians signed an open letter saying the bill could, quote, "place physicians at risk of frivolous lawsuits that threaten our ability to provide health care in Texas," unquote. Dr. Ghazaleh Moayedi is one of those who signed the letter. She is...
Related Articles
By Vittoria Vardanega, SWI swissinfo.ch | 02.13.2026
In recent years, sperm donation has produced family trees of unprecedented size, stretching across countries and, in some cases, continents. Stories of “mass donors” have captured public attention, most recently through the Netflix documentary series, The Man with 1,000 Kids...
By Jonathan D. Moreno, Hastings Center Bioethics Forum | 02.09.2026
When I began to write a book about bioethics and the rules-based international order, the idea that the world was facing the greatest geopolitical change since World War II was uncontroversial for those who were paying attention to such esoterica...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...